Co-encapsulation of collagenase type I and silibinin in chondroitin sulfate coated multilayered nanoparticles for targeted treatment of liver fibrosis
- 1 July 2021
- journal article
- research article
- Published by Elsevier in Carbohydrate Polymers
- Vol. 263, 117964
Abstract
No abstract availableKeywords
Funding Information
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- Major Technology Innovation of Hubei Province
This publication has 33 references indexed in Scilit:
- Comparison of LecT-Hepa and FibroScan for assessment of liver fibrosis in hepatitis B virus infected patients with different ALT levelsClinica Chimica Acta, 2012
- Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal AdenocarcinomaCancer Cell, 2012
- Effect of surface charge of polyethyleneimine-modified multiwalled carbon nanotubes on the improvement of polymerase chain reactionNanoscale, 2011
- Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administrationBiomaterials, 2010
- Doubly amphiphilic poly(2-oxazoline)s as high-capacity delivery systems for hydrophobic drugsBiomaterials, 2010
- Gene Expression, Biodistribution, and Pharmacoscintigraphic Evaluation of Chondroitin Sulfate−PEI Nanoconstructs Mediated Tumor Gene TherapyACS Nano, 2009
- Cytotoxicity of polyethyleneimine (PEI), precursor base layer of polyelectrolyte multilayer filmsBiomaterials, 2007
- Liver fibrosis – from bench to bedsideJournal of Hepatology, 2003
- Possible relevance of abnormal fatty acid metabolism in undernutrition: the relationship between oleic acid and growthMedical Hypotheses, 2000
- Characterization of the individual collagenases from Clostridium histolyticumBiochemistry, 1984